Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity
- PMID: 7535310
- PMCID: PMC227893
- DOI: 10.1128/jcm.33.1.126-130.1995
Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity
Abstract
Sera from patients with systemic infections caused by the opportunistic fungus Trichosporon beigelii have been shown to cross-react with anticryptococcal antibodies. We quantitatively compared the amounts of antigen produced and examined the expression of O-acetyl epitopes from 35 strains of T. beigelii isolated from deep and superficial infections. By counterimmunoelectrophoresis, 10 of 10 isolates from deep infections were positive for polysaccharide, compared with 7 of 13 isolates from superficial infections (P = 0.02). All 23 strains tested were positive for polysaccharide when screened by immunodot. By enzyme immunoassay, the cross-reactive antigen produced by deep isolates (n = 9) had a mean titer of 1:5,500. In contrast, superficial isolates (n = 22) produced significantly less antigen than the deep isolates (P < 0.001), with a mean titer of 1:700. Isolates from environmental sources (n = 3) were similar to the superficial isolates, with a mean titer of 1:600. The mean concentrations +/- standard errors of cross-reactive polysaccharide released by deep isolates and superficial isolates were 3.09 +/- 0.44 and 1.74 +/- 0.30 micrograms/ml, respectively, when measured by rocket immunoelectrophoresis (P = 0.02). O-Acetyl epitopes were detected on polysaccharide from 8 of 9 strains of T. beigelii isolated from deep sources, while only 2 of 12 superficial isolates expressed detectable O-acetyl epitopes (P = 0.01). Thus, while all isolates of T. beigelii tested were capable of producing glucuronoxylomannan-like cross-reactive antigen, pathogenic isolates produced significantly more antigen than superficial or environmental isolates. Furthermore, significantly more pathogenic isolates than superficial or environmental isolates expressed antigen that was O acetylated.
Similar articles
-
Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection.J Clin Microbiol. 1985 May;21(5):681-5. doi: 10.1128/jcm.21.5.681-685.1985. J Clin Microbiol. 1985. PMID: 3889042 Free PMC article.
-
Immunohistochemical identification of Trichosporon beigelii in histologic section by immunoperoxidase method.Am J Clin Pathol. 1988 Jan;89(1):100-5. doi: 10.1093/ajcp/89.1.100. Am J Clin Pathol. 1988. PMID: 3276138
-
Demonstration of a cell wall antigen cross-reacting with cryptococcal polysaccharide in experimental disseminated trichosporonosis.J Clin Microbiol. 1991 Jan;29(1):192-6. doi: 10.1128/jcm.29.1.192-196.1991. J Clin Microbiol. 1991. PMID: 1993757 Free PMC article.
-
[Disseminated Trichosporon beigelii infection: report of nine cases and review].Kansenshogaku Zasshi. 1993 Aug;67(8):704-11. doi: 10.11150/kansenshogakuzasshi1970.67.704. Kansenshogaku Zasshi. 1993. PMID: 8409577 Review. Japanese.
-
Trichosporon beigelii infection: experience in a regional burn center.Burns. 2000 Aug;26(5):483-6. doi: 10.1016/s0305-4179(99)00181-3. Burns. 2000. PMID: 10812273 Review.
Cited by
-
Fungal diagnostics in pneumonia.Semin Respir Crit Care Med. 2011 Dec;32(6):663-72. doi: 10.1055/s-0031-1295714. Epub 2011 Dec 13. Semin Respir Crit Care Med. 2011. PMID: 22167394 Free PMC article. Review.
-
Strain Typing of Trichosporon asahii Clinical Isolates by Random Amplification of Polymorphic DNA (RAPD) Analysis.J Lab Physicians. 2021 Sep;13(3):245-251. doi: 10.1055/s-0041-1731111. Epub 2021 Jul 2. J Lab Physicians. 2021. PMID: 34602789 Free PMC article.
-
In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.Infect Immun. 1999 Jun;67(6):3096-107. doi: 10.1128/IAI.67.6.3096-3107.1999. Infect Immun. 1999. PMID: 10338526 Free PMC article.
-
Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases.Open Forum Infect Dis. 2022 Oct 11;9(11):ofac535. doi: 10.1093/ofid/ofac535. eCollection 2022 Nov. Open Forum Infect Dis. 2022. PMID: 36381625 Free PMC article.
-
Successful treatment of breakthrough disseminated Trichosporon asahii fungemia in a patient with acute myeloid leukemia receiving itraconazole prophylaxis.Med Mycol Case Rep. 2017 Nov 28;20:1-3. doi: 10.1016/j.mmcr.2017.11.006. eCollection 2018 Jun. Med Mycol Case Rep. 2017. PMID: 29264110 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical